In the complex world of pharmaceutical synthesis, the quality and reliability of intermediate compounds are paramount. N-Phenyldiethanolamine (CAS 120-07-0) is one such crucial intermediate, playing a significant role, particularly in the development of advanced pharmaceuticals like anti-tumor agents. For researchers and procurement specialists in the pharmaceutical sector, understanding this compound and how to source it effectively is vital for successful drug development and manufacturing.

N-Phenyldiethanolamine, a chemical intermediate characterized by its slightly yellow crystalline appearance and the molecular formula C10H15NO2, is a key building block in organic synthesis. Its primary application within the pharmaceutical industry lies in its use as a precursor for potent drugs. Specifically, it is employed in the production of anti-tumor drugs such as N-formyl sarcolysin and other related anti-cancer agents. The efficacy and safety of these drugs are directly linked to the purity of the N-Phenyldiethanolamine used in their synthesis. Therefore, pharmaceutical manufacturers must prioritize sourcing this intermediate from suppliers who guarantee a high level of purity, typically ≥98.00%.

When a pharmaceutical company seeks to buy N-Phenyldiethanolamine, it is essential to partner with a manufacturer that adheres to stringent quality control standards. This includes providing detailed specifications, offering batch-specific Certificates of Analysis (CoA), and ensuring consistent product quality across all orders. The chemical properties of N-Phenyldiethanolamine, such as its solubility in common organic solvents like benzene and ethanol, are also important considerations for process chemists when designing synthesis routes. Furthermore, understanding its stability and recommended storage conditions – typically cool, dry environments away from moisture, heat, and light – ensures that the material remains viable for use.

The role of N-Phenyldiethanolamine extends beyond anti-tumor drug synthesis, serving as a versatile organic intermediate for various chemical processes. However, its impact on drug development is particularly noteworthy. As pharmaceutical companies scale up production, securing a stable and cost-effective supply chain for critical intermediates like N-Phenyldiethanolamine becomes a strategic imperative. Partnering with a reputable manufacturer, especially one based in China known for its chemical production capabilities, can offer significant advantages in terms of both price and availability.

For procurement professionals, initiating inquiries for bulk quantities of N-Phenyldiethanolamine should focus on suppliers who can demonstrate a deep understanding of pharmaceutical quality requirements. This might include information on their Good Manufacturing Practice (GMP) compliance, if applicable, or other quality assurance systems. Obtaining price quotes and samples for evaluation is a standard procedure to ensure that the procured intermediate meets the precise specifications required for sensitive pharmaceutical applications.

In conclusion, N-Phenyldiethanolamine (CAS 120-07-0) is a vital chemical compound that enables the creation of critical pharmaceutical products, most notably anti-tumor drugs. Its purity and consistent quality are non-negotiable for the pharmaceutical industry. By strategically sourcing this intermediate from experienced and quality-focused manufacturers and suppliers, pharmaceutical companies can ensure the success of their drug synthesis pipelines and contribute to advancements in healthcare.